Cargando…

Tumor Microenvironment and Immunotherapy-Based Approaches in Mantle Cell Lymphoma

SIMPLE SUMMARY: Mantle cell lymphoma (MCL) is associated with poor response to anthracycline-based chemotherapy, and high-dose cytarabine offers a durable response. Recently, multiple targeted therapies have been approved for the treatment of MCL, highlighting the role of the tumor microenvironment...

Descripción completa

Detalles Bibliográficos
Autores principales:	Saleh, Khalil, Cheminant, Morgane, Chiron, David, Burroni, Barbara, Ribrag, Vincent, Sarkozy, Clémentine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9265015/ https://www.ncbi.nlm.nih.gov/pubmed/35804999 http://dx.doi.org/10.3390/cancers14133229

Ejemplares similares

P1079: VERY LONG-TERM FOLLOW-UP OF RITUXIMAB MAINTENANCE IN YOUNG PATIENTS WITH MANTLE CELL LYMPHOMA INCLUDED IN THE LYMA TRIAL, A LYSA STUDY.
por: Sarkozy, Clementine, et al.
Publicado: (2023)

Updates in the Treatment of Peripheral T-Cell Lymphomas
por: Saleh, Khalil, et al.
Publicado: (2021)

Droplet Digital PCR Quantification of Mantle Cell Lymphoma Follow-up Samples From Four Prospective Trials of the European MCL Network
por: Drandi, Daniela, et al.
Publicado: (2020)

BMP7 Expression Correlates with Secondary Drug Resistance in Mantle Cell Lymphoma
por: Camara-Clayette, Valérie, et al.
Publicado: (2013)

CD8+ T Lymphocytes Immune Depletion and LAG-3 Overexpression in Hodgkin Lymphoma Tumor Microenvironment Exposed to Anti-PD-1 Immunotherapy
por: Michot, Jean-Marie, et al.
Publicado: (2021)

Combined epigenetic and immunotherapy for blastic and classical mantle cell lymphoma
por: LeBlanc, Francis R., et al.
Publicado: (2022)

Clinical significance of the loss of CD20 antigen on tumor cells in patients with relapsed or refractory follicular lymphoma
por: Michot, Jean-Marie, et al.
Publicado: (2021)

Immune-depleted tumor microenvironment is associated with poor outcomes and BTK inhibitor resistance in mantle cell lymphoma
por: Jain, Preetesh, et al.
Publicado: (2023)

Single nucleotide variants in immune-response genes and the tumor microenvironment composition predict progression of mantle cell lymphoma
por: Assis-Mendonça, Guilherme Rossi, et al.
Publicado: (2021)

Positron emission tomography-computed tomography before autologous stem cell transplant in follicular lymphoma: coming too late?
por: Sarkozy, Clémentine, et al.
Publicado: (2022)

The prognostic value of clonal heterogeneity and quantitative assessment of plasma circulating clonal IG-VDJ sequences at diagnosis in patients with follicular lymphoma
por: Sarkozy, Clémentine, et al.
Publicado: (2017)

Reappraisal of the use of procarbazine in the treatment of lymphomas and brain tumors
por: Armand, Jean-Pierre, et al.
Publicado: (2007)

The REFRACT-LYMA cohort study: a French observational prospective cohort study of patients with mantle cell lymphoma
por: Hanf, Matthieu, et al.
Publicado: (2016)

Smoldering mantle cell lymphoma
por: Ye, Haige, et al.
Publicado: (2017)

The “Trojan Horse” Approach to Tumor Immunotherapy: Targeting the Tumor Microenvironment
por: Nelson, Delia, et al.
Publicado: (2014)

Tumor flare reaction in a patient with mantle cell lymphoma
por: Kayar, Yusuf, et al.
Publicado: (2014)

Spontaneous tumor lysis syndrome in hyperaggressive mantle cell lymphoma
por: Wilson, James
Publicado: (2022)

Mantle Cell Lymphoma Relapsing at the Lymphedematous Arm
por: Massini, Giuseppina, et al.
Publicado: (2013)

Regulatory T Cells in Tumor Microenvironment and Approach for Anticancer Immunotherapy
por: Kim, Jung-Ho, et al.
Publicado: (2020)

A case of mantle cell lymphoma presenting with ascites
por: Al‐Nabulsi, Majdi, et al.
Publicado: (2016)

Hedgehog inhibitors selectively target cell migration and adhesion of mantle cell lymphoma in bone marrow microenvironment
por: Zhang, Han, et al.
Publicado: (2016)

Inhibition of focal adhesion kinase overcomes resistance of mantle cell lymphoma to ibrutinib in the bone marrow microenvironment
por: Rudelius, Martina, et al.
Publicado: (2018)

P1246: DIFFERENTIAL ROLE OF MICROENVIRONMENT AND STROMAL-CELL INDUCED VENETOCLAX RESISTANCE IN MANTLE CELL LYMPHOMA
por: Andersen, P., et al.
Publicado: (2022)

Aggressive, early resistant and relapsed mantle cell lymphoma distinct extrinsic microenvironment highlighted by transcriptome analysis
por: Le Bris, Yannick, et al.
Publicado: (2022)

Editorial: Novel treatments for diffuse large B-cell lymphoma: The post-CART era
por: Mussetti, Alberto, et al.
Publicado: (2022)

Mantle cell lymphoma with features of marginal-zone lymphoma
por: Randen, Ulla, et al.
Publicado: (2011)

Novel Treatments of Adult T Cell Leukemia Lymphoma
por: El Hajj, Hiba, et al.
Publicado: (2020)

Primary gastric mantle cell lymphoma
por: Petranovic, Duska, et al.
Publicado: (2012)

Mantle cell lymphoma with skin involvement
por: Kalińska-Bienias, Agnieszka, et al.
Publicado: (2015)

Esophageal location of mantle cell lymphoma
por: Michopoulos, Spyros
Publicado: (2016)

Tracheobronchial involvement of mantle cell lymphoma
por: Tong, Lin, et al.
Publicado: (2018)

Mantle Cell Lymphoma Case Report
por: Podzolkov, V.I., et al.
Publicado: (2018)

Educational Case: Mantle Cell Lymphoma
por: Mai, Brenda, et al.
Publicado: (2020)

Emerging therapies in mantle cell lymphoma
por: Hanel, Walter, et al.
Publicado: (2020)

Tackling Mantle Cell Lymphoma in Europe
por: Horgan, Denis, et al.
Publicado: (2022)

Mantle cell lymphoma: a model for risk-adapted treatment approach
por: Kim, Seok Jin
Publicado: (2014)

Circulating tumor DNA predicts therapeutic outcome in mantle cell lymphoma
por: Lakhotia, Rahul, et al.
Publicado: (2022)

Cell-free DNA sequencing as a potential screening tool for phase I targeted treatment in refractory/relapse diffuse large B-cell lymphoma
por: Quivoron, Cyril, et al.
Publicado: (2022)

Mantle Cell Lymphoma of Mucosa-Associated Lymphoid Tissue: A European Mantle Cell Lymphoma Network Study
por: Morello, Lucia, et al.
Publicado: (2019)

The influence of microenvironment on tumor immunotherapy
por: Zhang, Jieying, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_apuf1nqek0bj2f1okapk08jnj7